148
Participants
Start Date
October 28, 2021
Primary Completion Date
June 23, 2025
Study Completion Date
October 30, 2025
savolitinib
Tablets : 3 × 200 mg tablets once daily
durvalumab
Concentrate for solution for IV infusion : 1500 mg durvalumab every 4 weeks
sunitinib
Capsules : 2 x 25mg capsules once daily 4 weeks on, 2 weeks off
Research Site, Tainan City
Research Site, Ciudad Autónoma Buenos Aires
Research Site, La Plata
Research Site, St Leonards
Research Site, Macquarie University
Research Site, Box Hill
Research Site, Córdoba
Research Site, New York
Research Site, Goyang-si
Research Site, Córdoba
Research Site, Prague
Research Site, A Coruña
Research Site, Milan
Research Site, Aguascalientes
Research Site, Hamburg
Research Site, Edirne
Research Site, Madrid
Research Site, Madrid
Research Site, Madrid
Research Site, Majadahonda
Research Site, Málaga
Research Site, Quimper
Research Site, Hanover
Research Site, Pamplona
Research Site, Toulouse
Research Site, Istanbul
Research Site, Bordeaux
Research Site, Istanbul
Research Site, Istanbul
Research Site, Daejeon
Research Site, Izmir
Research Site, Padua
Research Site, Karşıyaka
Research Site, Verona
Research Site, Bologna
Research Site, Taichung
Research Site, Seville
Research Site, Reggio Emilia
Research Site, Valencia
Research Site, Meldola
Research Site, Dnipropetrovsk
Research Site, Petah Tikva
Research Site, Toluca
Research Site, Florence
Research Site, Arezzo
Research Site, Monterrey
Research Site, Bari
Research Site, Tricase
Research Site, Querétaro
Research Site, Napoli
Research Site, München
Research Site, Avellino
Research Site, Kaohsiung City
Research Site, Ulm
Research Site, Haifa
Research Site, Villejuif
Research Site, Beijing
Research Site, Shenyang
Research Site, Harbin
Research Site, Singapore
Research Site, Shanghai
Research Site, Craiova
Research Site, Nanjing
Research Site, Jinan
Research Site, Tianjin
Research Site, Jaipur
Research Site, Cluj-Napoca
Research Site, Chongqing
Research Site, Cluj-Napoca
Research Site, Changsha
Research Site, Changsha
Research Site, Nashik
Research Site, Zhengzhou
Research Site, Bangalore
Research Site, Mysore
Research Site, Belagavi
Research Site, Temuco
Research Site, Santiago
Research Site, Providencia
Research Site, Santiago
Research Site, Boston
Research Site, Buenos Aires
Research Site, CABA
Research Site, Ciudad Autonoma Buenos Aires
Research Site, Rosario
Research Site, San Miguel de Tucumán
Research Site, Belo Horizonte
Research Site, Brasília
Research Site, Cachoeiro de Itapemirim
Research Site, Criciúma
Research Site, Curitiba
Research Site, Florianópolis
Research Site, Fortaleza
Research Site, Natal
Research Site, Pelotas
Research Site, Porto Alegre
Research Site, Porto Alegre
Research Site, Rio de Janeiro
Research Site, Salvador
Research Site, São Jose Do Rio Preto
Research Site, São Paulo
Research Site, São Paulo
Research Site, Săo Paulo
Research Site, Vitória
Research Site, Calgary
Research Site, Montreal
Research Site, Montreal
Research Site, Brno
Research Site, Hradec Králové
Research Site, Olomouc
Research Site, Prague
Research Site, Prague
Research Site, Prague
Research Site, Hong Kong
Research Site, Shatin
Research Site, Amsterdam
Research Site, Arnhem
Research Site, Rotterdam
Research Site, Gdansk
Research Site, Gdynia
Research Site, Krakow
Research Site, Otwock
Research Site, Poznan
Research Site, Incheon
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Barcelona
Research Site, Barcelona
Research Site, Barcelona
Research Site, Adana
Research Site, Ankara
Research Site, Ankara
Research Site, Ankara
Research Site, Kazımkarabekir
Research Site, Leicester
Research Site, London
Research Site, London
Lead Sponsor
AstraZeneca
INDUSTRY